Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative determination of retrovirus-specific immune complexes.

H Schetters1, H Rohmer, R Hehlmann

  • 1Medizinische Poliklinik, Ludwig-Maximilians-Universität, Munich, F.R.G.

Journal of Immunological Methods
|November 6, 1990
PubMed
Summary

A new ELISA method quantifies retroviral antigen-specific immune complexes (ASIC) by measuring antibody and antigen levels. This technique determines ASIC composition and correlates with C1q ELISA, enabling measurement in mouse sera.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020
Same author

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Leukemia·2018
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same author

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Leukemia·2017
Same author

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016
Same author

Prof. Thomas Büchner (22 September 1934-5 August 2016)-A leading European hematologist and AML trialist.

Leukemia·2016

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • Immune complexes (ICs) play a role in various diseases.
  • Quantifying antigen-specific immune complexes (ASIC) is crucial for understanding immune responses.
  • Existing methods may lack specificity or detailed compositional analysis.

Purpose of the Study:

  • To adapt and validate an ELISA methodology for measuring retroviral ASIC.
  • To determine the composition of ASIC, including antigen or antibody excess.
  • To correlate ASIC levels with existing IC detection methods.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) adapted for ASIC detection.
  • Utilized artificial ICs composed of MuLV gp70 and specific monoclonal antibodies.

Related Experiment Videos

  • Quantified ICs by measuring individual antibody and antigen levels relative to total IC content.
  • Correlated ASIC levels with C1q ELISA results for undefined antigen-containing ICs.

    • Main Results:

    • Successfully quantified artificially generated ICs containing MuLV gp70.
    • Demonstrated the ability to determine ASIC composition (antigen-excess or antibody-excess complexes).
    • Showed a correlation between ASIC levels and those detected by C1q ELISA.
    • Enabled the measurement of MuLV gp70-specific ICs in various mouse sera.

    Conclusions:

    • The adapted ELISA methodology provides a reliable way to quantify retroviral ASIC.
    • This method allows for detailed analysis of IC composition.
    • The findings support the utility of this ELISA for immunological studies involving retroviral antigens in serum samples.